Morgan Apolonio Rose Hills
Cyanobacterial Production of Biopharmaceutical Proteins
Synechocystis sp. PCC 6803 (Synechocystis) is a fast-growing unicellular photosynthetic microorganism comprising a potential cell factory for the generation of bioactive compounds, therapeutic proteins, and biofuels. Fusion constructs of recombinant proteins with the CpcB β-subunit of the light-harvesting phycocyanin in Synechocystis has enabled the over-expression of proteins of interest up to 10-20% of the total cellular protein. I will use human interferon α-2 protein (IFN), a human immunoprotein that protects cells from infection, as a case study of over-expression and downstream signal processing of IFN. One problem in the biosynthesis of compounds is the release from the CpcB β-subunit, and this project seeks to remedy that. By using the tobacco etch virus protease, I hope to develop the technology of target protein separation from the phycocyanin fusion construct. This will bring the cyanobacterial cell factory concept closer to commercial application.